General MedicationsORALGeneric
DORMATE
MEBUTAMATE
Standard Dose
600MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview DORMATE is listed in Drugs@FDA under application 017374 (NDA).
Marketing status: Discontinued Active ingredient MEBUTAMATE Form and strength TABLET;ORAL - 600MG Sponsor MEDPOINTE PHARM HLC Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview DORMATE is listed in Drugs@FDA under application 017374 (NDA). Marketing status: Discontinued Active ingredient MEBUTAMATE Form and strength TABLET;ORAL - 600MG Sponsor MEDPOINTE PHARM HLC Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.